Navigation Links
District nursing homes win high marks for quality, but antipsychotic prescribing remains problematic

WASHINGTON, DC (October 17, 2013)The District of Columbia Department of Health (DOH) has released a study by the George Washington University School of Public Health and Health Services (SPHHS) investigating prescribing of antipsychotics to District seniors. The study combines pharmaceutical marketing data collected by the District with publicly available data on nursing home quality and Medicare drug claims.

"The good news is that nursing homes in the District of Columbia generally are not prescribing antipsychotic medication at rates higher than the rest of the country," says Susan F. Wood, PhD, lead researcher and an associate professor of health policy and of environmental and occupational health at SPHHS. "However, there are still concerns that District providers are too quick to prescribe these drugs to District seniors and Medicaid beneficiaries."

Antipsychotics are one of the top-selling drug classes, despite widely reported side effects that include weight gain and sedation. Elderly patients suffering from dementia or agitation may be dosed with antipsychotics for their sedative effects, an off-label use that raises ethical questions. Use of antipsychotics puts seniors at increased risk of serious adverse events, including cognitive decline, hip fractures, and death.

"Senior citizens living in the District of Columbia are the city's most vulnerable population," said Dr. Joxel Garcia, Director, DC Department of Health. "The Department of Health will continue to invest in educating physicians on effective use of antipsychotic medications to provide the better health outcomes for all District residents."

The report fulfills the requirement of a 2004 law in the District of Columbia that requires pharmaceutical companies to file annual reports describing their prescription-drug marketing activities in the District. The AccessRx Act also requires analysis of these reports to determine how pharmaceutical marketing may affect healthcare services in the District.

SPHHS researchers searched District of Columbia marketing data for reports of drug-company gifts made in 2007 - 2011 to physicians who currently serve as nursing home medical directors. The search was done to see if pharmaceutical companies were targeting marketing efforts at the medical directors of nursing homes. The report found that nine of the district's 19 nursing home medical directors received no gifts from pharmaceutical companies between 2007 and 2011. Three received cash or checks for speaking or consulting, which totaled $34,639 over five years. Only four received gifts totaling over $1,000 in at least one of the years studied; six received gifts, mostly food or books, totaling $100 to $800 in at least one year.

The study also examined nursing home quality ratings and rates of antipsychotic prescriptions across eight wards in the district, using ratings from the Nursing Home Compare website run by the Centers for Medicare and Medicaid Services (CMS). Thirteen of the District's 19 nursing homes received above-average ratings (four or five stars) for overall quality. The two nursing homes with the lowest ratings (two stars, or "below average") are both located in Ward 7.

Nursing Home Compare also reports the percentage of short-stay nursing home patients receiving new antipsychotic prescriptions and the percentage of long-stay patients receiving antipsychotic medications. In the District, seven out of 18 nursing homes have above‐average prescribing rates for short‐stay patients, and six out of 19 have above‐average rates of long‐stay patients taking antipsychotics. (Average US rates are 2.7 percent for short-stay patients and 22.4 percent for long-stay patients.)

Researchers also examined data on prescriptions of antipsychotics for Medicare Part D patients, the majority of whom are seniors. The SPHHS report compiles information on 67 District providers who wrote antipsychotic prescriptions for large numbers of Part D patients. Nearly one-third (22 of 67) of these prescribed at least one antipsychotic to 70 percent or more of their Part D patients.

"Many doctors in the District write significant numbers of prescriptions of antipsychotic medication to Medicare patients. This provides a window into prescribing practices here," says Adriane Fugh-Berman, MD, a co-author of the report and an associate professor of pharmacology and physiology at Georgetown University Medical Center.

"As we noted in an earlier report for the Department of Health, the District has a very high percentage of Medicaid beneficiaries receiving antipsychotic medications," Wood says. Data released by CMS just after this report was written indicate that nearly 11 percent of the District's Medicaid beneficiaries filled antipsychotic prescriptions in 2009. "High rates of prescribing antipsychotics, whether to children or elders, raises concerns about the quality of care provided to low-income District residents and the role of pharmaceutical marketing in prescribing practices."

The study can be found on the D.C. Department of Health Website by clicking here.


Contact: Kathy Fackelmann
George Washington University School of Public Health and Health Services

Related medicine news :

1. Pelvic Mesh Manufacturers Allegedly in Settlement Talks as Patients’ Attorneys in Multidistrict Litigations Seek Creation of a Settlement Committee, Notes Parker Waichman
2. San Francisco's SOMA (South of Market) District Apartment Rentals At 99% Capacity, Announces 1188 Mission at Trinity Place.
3. Mirena Lawsuit Update: Bernstein Liebhard LLP Reports on Growing Number of Mirena IUD Lawsuits Pending in Federal Multidistrict Litigation
4. DePuy Orthopaedics Inc.’s Multidistrict Litigation Update: First Bellwether Trial to Commence Within 90 Days, Parker Waichman LLP Reports
5. Biomet Hip Replacement News: Federal Multidistrict Litigation for Biomet Hip Lawsuits to Hold Status Conference, Bernstein Liebhard LLP Reports
6. Transvaginal Mesh Multidistrict Litigation Update: Judge Makes Pretrial Ruling on Document Production, Reports Parker Waichman LLP
7. Judge Orders Postponement of First Bellwether Trial in DePuy Orthopaedics Inc.’s Multidistrict Litigation, Pushing It to Sept. 24, Parker Waichman LLP Reports
8. Pradaxa Bleeding Lawyers at Wright & Schulte LLC Note Growing Number of Filings in Federal Multidistrict Litigation Established for Pradaxa Lawsuits
9. Dr. Christine Fialka-Eshenko Elected to Legacy Project Chair of Edmonton and District Dental Society
10. C8 Lawsuit Lawyers at Wright & Schulte LLC Applaud Scheduling of First Trials in Multidistrict Litigation Established for Federal DuPont C8 Lawsuits
11. Dr. Daniel Rose, Medical Director for Healdsburg District Hospital’s Wound Care Program Anticipates Growth and Technology for the Innovative North Bay Program
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... The Museum of Science & ... a new era of publicly accessible automated technology. Now, by popular demand, the ... guests an up-close look at the shuttle at MOSI’s main entrance. This experience ...
(Date:11/30/2015)... ... November 30, 2015 , ... The presidential race normally deals ... So why is it a national news story when Donald Trump makes disparaging remarks ... because appearances count more than anyone wants to admit when it comes to how ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... course in Dallas, TX, on January 29 and 30, 2016. The course welcomes ... functions of their practices, to learn how to better succeed in the modern ...
(Date:11/30/2015)... Georgia (PRWEB) , ... November 30, 2015 , ... ... of a key disease-causing component of bacteria could be effective in fighting methicillin-resistant ... at Georgia State University. , Their study showed that small molecule analogs that ...
(Date:11/30/2015)... ... November 30, 2015 , ... Dr. Seth D. Margulies specializes in orthodontics ... visit Dr. Margulies to experience the best available orthodontic experience in the area. ... Top Dentist"! , Orthodontics is the branch of dentistry that specializes in the diagnosis, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... ) has ... Market 2015-2019" report to their offering. ... of the "Orphan Drugs Market 2015-2019" ... and Markets ( ) has announced the ... report to their offering. ...
(Date:11/30/2015)... Next week, December 2-3, BIOMEDevice San ... co-located events covering the latest in Medtech innovation, Wearable ... draw more than 3,000 design industry professionals to the ... events, combined show floor will host more than 300 ... --> --> BIOMEDevice features suppliers in ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North ... and distribution of radiopharmaceuticals, announced that as of January ... Inc. (Zevacor Pharma). The decision to rebrand the company ... firm as well as its close relationship with Zevacor ... Illinois Health and Science (IHS). Peter ...
Breaking Medicine Technology: